|本期目录/Table of Contents|

[1]郝广杰,任国成,邢立莹.辽西农村地区高血压知晓、治疗和控制现状及相关因素分析[J].慢性病学杂志,2020,21(02):180-185.
 HAOGuang-jie *,RENGuo-cheng,XINGLi-ying.Analysis of current status of awareness, treatment, control of hypertension and related factors in rural areas of western Liaoning province[J].,2020,21(02):180-185.
点击复制

辽西农村地区高血压知晓、治疗和控制现状及相关因素分析

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
21
期数:
2020年02期
页码:
180-185
栏目:
论 著
出版日期:
2020-02-28

文章信息/Info

Title:
Analysis of current status of awareness, treatment, control of hypertension and related factors in rural areas of western Liaoning province
作者:
郝广杰12任国成2邢立莹3
1.承德医学院,承德 067000; 2.朝阳市中心医院,辽宁 朝阳 122000; 3.辽宁省疾病预防控制中心,沈阳 110000
Author(s):
HAOGuang-jie * RENGuo-chengXINGLi-ying
*ChengdeMedicai College, Chengde067000,Hebei,China Correspondingauthor:RENGuocheng,E-mail:591413362@qq.com
关键词:
高血压患病率知晓治疗控制
Keywords:
Hypertension Prevalence Awareness Treatment Control
分类号:
R589
DOI:
-
摘要:
目的 通过对辽西农村地区调查,评估高血压的流行情况,为指导该地区高血压管理提供相关策略。 方法 于2017年9月—2018年5月在辽西农村地区获得6 097例年龄≥40岁常住居民的代表性样本,通过采集调 查对象的基本信息、生活方式信息、家族史、体格检查以及血压情况等,进行逐步逻辑回归分析确定高血压知 晓、治疗以及控制的相关影响因素。结果 调查对象39.59%为男性,平均年龄(60.40±10.20)岁;60.41%为 女性,平均年龄(58.33±10.33)岁,高血压患病率、知晓率、治疗率、控制率和治疗控制率分别为58.00%、 48.33%、34.50%、4.27%以及12.38%。其中年龄、性别、BMI、饮酒、饮食习惯、糖尿病、脑卒中和高血压家 族史与知晓率、治疗率有关;婚姻状况、血脂异常同样与高血压治疗率有关;而与高血压控制率有关的因素是性 别、糖尿病、脑卒中以及高血压家族史(P<0.05)。结论 辽西农村地区高血压患病率较高,通过相关风险因素 的分析可指导本地区高血压的干预措施,以提高当地居民高血压的认识、治疗和控制。
Abstract:
Objective To assess the prevalence of hypertension in rural areas of western Liaoning prov-ince, and to provide relevant strategies for guiding the management of hypertension in these areas. Methods From September2017 to May 2018, a sample of 6 097 permanent residents aged 40 or more was obtained in rural areas of western Liaoning. Their basic information, lifestyle, family histo-ry, physical examination and blood pressure were collected. Stepwise logistic regression analysis was performed to determine the relevant influencing factors of hypertension awareness, treatment, and con-trol. Results The sample subjects had39.59% of men with average age of(60.40±10.20)years old and 60.41% of women with average age of(58.33±10.33)years old. The prevalence, awareness, treat-ment, control rates and treatment control rate of hypertension were58.00%,48.33%,34.50%,4.27% and 12.38%, respectively. The age, sex, BMI, drink, diet, diabetes, stroke, and family history of hy-pertension were related to the awareness and treatment rates. Marital status and dyslipidemia were also related to the treatment rate of hypertension. Factors associated with hypertension control rates were sex, diabetes, stroke, and family history of hypertension(P<0.05). Conclusion There is a high prevalence of hypertension in rural areas of western Liaoning province, and the analysis of relevant riskfactors can guide the intervention measures of hypertension in this region, so as to improve the aware-ness, treatment and control of hypertension in local residents.

参考文献/References:

[1] Kearney PM, Whelton M, Reynolds K,et al. Global bur-den of hypertension: analysis of worldwide data [J]. Lan-cet, 2005,365(9455):217-223. [2] Forouzanfar MH, Liu P, Roth GA,et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg,1990-2015 [J]. JAMA, 2017,317(2): 165-182. [3] GBD2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study2017[J]. Lancet,2018,392(10159):1684-1735. [4] Zanchetti A, Thomopoulos C, Parati G, et al. Random-ized controlled trials of blood pressure lowering in hyper-tension: a critical reappraisa [J]. Circ Res, 2015,116(6): 1058-73. [5] Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet,2019,pii:S0140-6736(19)30427-30431. [6] Zhao Y, Hu Y, Smith JP,et al. Cohort profile: the China health and retirement longitudinal study (CHARLS) [J]. Int J Epidemiol, 2014,43(1):61-8. [7] Wang Z, Chen Z, Zhang L,et al. Status of Hypertension in China: Results from the China Hypertension Survey, 2012-2015[J]. Circulation, 2018,137(22):2344-2356. [8] Irazola VE, Gutierrez L, Bloomfield G, et al. Hyperten-sion Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities: Results From the NHLBI/ UHG Network of Centers of Excellence for Chronic Dis-eases [J]. Glob Heart, 2016,11(1):47-59. [9] 刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19 (8):701-743. [10] Lu J, Lu Y, Wang X,etal. Prevalence, awareness, treat-ment, and control of hypertension in China: data from1·7 million adults in a population-based screening study (China PEACE Million Persons Project) [J]. Lancet, 2017,390 (10112):2549-2558. [11] 张艳妮,曾繁慧,包研科,等.辽宁省阜新农村地区人群高血压危 险因素分析[J].中华高血压杂志,2017,25(10):937-941. [12] 田爱红,田蕊,张润华,等.北京市石景山社区居民高血压知晓率、 治疗率和控制率及影响因素的相关研究[J].中国卒中杂志,2017, 12(9):794-799.[13] 宓伟,尹淑英,练武,等.烟台市农村老年人高血压知晓率、治疗率 和控制率的现状及其影响因素[J].中国老年学杂志,2015,35(21): 6220-6222. [14] Dastan I, Erem A, Cetinkaya V. Awareness, treatment, control of hypertension, and associated factors: Results from a Turkish national study [J]. Clin Exp Hypertens, 2018,40(1):90-98. [15] 张丹薇,崔建兰,吴超群,等.我国西南地区年龄35~75岁成人高血压 知晓、治疗和控制现状[J].中华高血压杂志,2019,27(3):235-241. [16] Mohamed SF, Mutua MK, Wamai R,et al. Prevalence, awareness, treatment and control of hypertension and their determinants: results from a national survey in Kenya [J]. BMC public health,2018,18(Suppl 3). [17] Morris AB, Li J, Kroenke K,et al. Factors associat-ed with drug adherence and blood pressure control in pa-tients with hypertension [J]. Pharmacotherapy, 2006,26(4): 483-492. [18] DiMatteo MR. Social support and patient adherence to medical treatment: a meta- analysis [J]. Health Psychol, 2004,23(2):207-218. [19] Lloyd- Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and con-trol in the community [J]. JAMA, 2005(294):466-472. [20] Nguyen QT, Anderson SR, Sanders L,etal. Managing hy-pertension in the elderly: a common chronic disease with in-creasing age [J]. Am Health Drug Benefts,2012(5):146-153.

备注/Memo

备注/Memo:
作者简介:郝广杰,硕士研究生,研究方向:心血管病方向 通讯作者:任国成,E-mail:591413362@qq.com
更新日期/Last Update: 2020-02-28